{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:40:23Z","timestamp":1792010423289,"version":"4.4.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangxi Natural Science Foundation Project","award":["2024GXNSFBA010152"],"award-info":[{"award-number":["2024GXNSFBA010152"]}]},{"name":"Self-funded Research Project of the Health Commission of Guangxi Zhuang Autonomous Region","award":["Z-A20250497"],"award-info":[{"award-number":["Z-A20250497"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation Project of China","doi-asserted-by":"crossref","award":["8226120190"],"award-info":[{"award-number":["8226120190"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48284-x","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T05:54:13Z","timestamp":1777701253000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Circulating IL-33 as a sensitive alarmin in systemic lupus erythematosus: a biomarker for disease activity and skin-specific manifestations"],"prefix":"10.1038","volume":"16","author":[{"given":"Li","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijian","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runge","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youkun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"key":"48284_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.984229","volume":"9","author":"J Elmgren","year":"2023","unstructured":"Elmgren, J. & Nyberg, F. Clinical aspects of cutaneous lupus erythematosus. Front. Med. 9, 984229 (2023).","journal-title":"Front. Med."},{"issue":"21","key":"48284_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111327","volume":"22","author":"H Idborg","year":"2021","unstructured":"Idborg, H. & Oke, V. Cytokines as biomarkers in systemic lupus erythematosus: Value for diagnosis and drug therapy. Int. J. Mol. Sci. 22(21), 11327 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"48284_CR3","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028506","volume":"11","author":"A Vasanthakumar","year":"2019","unstructured":"Vasanthakumar, A. & Kallies, A. Interleukin (IL)-33 and the IL-1 family of cytokines\u2014Regulators of inflammation and tissue homeostasis. Cold Spring Harb. Perspect. Biol. 11(3), a028506 (2019).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"48284_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cells11203237","volume":"11","author":"H Guo","year":"2022","unstructured":"Guo, H., Bossila, E. A., Ma, X., Zhao, C. & Zhao, Y. Dual immune regulatory roles of Interleukin-33 in pathological conditions. Cells 11, 3237 (2022).","journal-title":"Cells"},{"issue":"12","key":"48284_CR5","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/s41573-025-01242-0","volume":"24","author":"M Scherlinger","year":"2025","unstructured":"Scherlinger, M. et al. Advances in the treatment of systemic lupus erythematosus. Nat. Rev. Drug Discov. 24(12), 926\u2013944 (2025).","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"48284_CR6","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41584-025-01277-y","volume":"21","author":"GJ Pons-Estel","year":"2025","unstructured":"Pons-Estel, G. J. et al. Addressing the challenge of global delays in diagnosis and treatment of systemic lupus erythematosus. Nat. Rev. Rheumatol. 21(9), 566\u2013574 (2025).","journal-title":"Nat. Rev. Rheumatol."},{"issue":"10441","key":"48284_CR7","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1016\/S0140-6736(24)00398-2","volume":"403","author":"A Hoi","year":"2024","unstructured":"Hoi, A. et al. Systemic lupus erythematosus. Lancet 403(10441), 2326\u20132338 (2024).","journal-title":"Lancet"},{"issue":"8","key":"48284_CR8","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/s41590-024-01898-7","volume":"25","author":"GC Tsokos","year":"2024","unstructured":"Tsokos, G. C. The immunology of systemic lupus erythematosus. Nat. Immunol. 25(8), 1332\u20131343 (2024).","journal-title":"Nat. Immunol."},{"key":"48284_CR9","unstructured":"Sammaritano, L. R., Askanase, A., Bermas, B. L., et al. 2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus. Arthritis Care Res. (2025)."},{"key":"48284_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2019.107135","volume":"83","author":"J Kong","year":"2019","unstructured":"Kong, J. et al. Potential protein biomarkers for systemic lupus erythematosus determined by bioinformatics analysis. Comput. Biol. Chem. 83, 107135 (2019).","journal-title":"Comput. Biol. Chem."},{"issue":"2","key":"48284_CR11","first-page":"1","volume":"86","author":"X Lu","year":"2025","unstructured":"Lu, X., Yan, S. & Xue, Y. Exploring the relationship between serum IL-33 levels and clinical manifestations in systemic lupus erythematosus: A comprehensive analysis. Br. J. Hosp. Med. (Lond.) 86(2), 1\u201312 (2025).","journal-title":"Br. J. Hosp. Med. (Lond.)"},{"key":"48284_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molimm.2016.07.001","volume":"77","author":"J Guo","year":"2016","unstructured":"Guo, J. et al. The association of novel IL-33 polymorphisms with sIL-33 and risk of systemic lupus erythematosus. Mol. Immunol. 77, 1\u20137 (2016).","journal-title":"Mol. Immunol."},{"issue":"2","key":"48284_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10238-010-0115-4","volume":"11","author":"Z Yang","year":"2011","unstructured":"Yang, Z. et al. Association of increased serum IL-33 levels with clinical and laboratory characteristics of systemic lupus erythematosus in Chinese population. Clin. Exp. Med. 11(2), 75\u201380 (2011).","journal-title":"Clin. Exp. Med."},{"key":"48284_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.clim.2019.03.008","volume":"202","author":"C Guo","year":"2019","unstructured":"Guo, C. et al. Innate lymphoid cell disturbance with increase in ILC1 in systemic lupus erythematosus. Clin. Immunol. 202, 49\u201358 (2019).","journal-title":"Clin. Immunol."},{"issue":"5","key":"48284_CR15","first-page":"897","volume":"40","author":"A Moreau","year":"2022","unstructured":"Moreau, A. et al. Soluble ST2 is increased in systemic lupus erythematous and is a potential marker of lupus nephritis. Clin. Exp. Rheumatol. 40(5), 897\u2013903 (2022).","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"48284_CR16","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/rheumatology\/kep402","volume":"49","author":"MY Mok","year":"2010","unstructured":"Mok, M. Y. et al. Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus. Rheumatology (Oxford) 49(3), 520\u2013527. https:\/\/doi.org\/10.1093\/rheumatology\/kep402 (2010).","journal-title":"Rheumatology (Oxford)"},{"key":"48284_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2023.117609","volume":"551","author":"Z Ye","year":"2023","unstructured":"Ye, Z., Zhang, T., Xu, M. & Xu, J. Association of soluble ST2 with disease activity in pediatric systemic lupus erythematosus. Clin. Chim. Acta 551, 117609. https:\/\/doi.org\/10.1016\/j.cca.2023.117609 (2023).","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"48284_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ajpath.2011.03.010","volume":"179","author":"SN Byrne","year":"2011","unstructured":"Byrne, S. N. et al. The immune-modulating cytokine and endogenous Alarmin interleukin-33 is upregulated in skin exposed to inflammatory UVB radiation. Am. J. Pathol. 179(1), 211\u2013222 (2011).","journal-title":"Am. J. Pathol."},{"key":"48284_CR19","doi-asserted-by":"publisher","first-page":"4955761","DOI":"10.1155\/2022\/4955761","volume":"2022","author":"Y Song","year":"2022","unstructured":"Song, Y. et al. IL-33\/ST2 activation is involved in Ro60-regulated photosensitivity in cutaneous lupus erythematosus. Mediators Inflamm. 2022, 4955761 (2022).","journal-title":"Mediators Inflamm."},{"issue":"2","key":"48284_CR20","doi-asserted-by":"publisher","first-page":"302","DOI":"10.4049\/jimmunol.2000905","volume":"206","author":"JH Sim","year":"2021","unstructured":"Sim, J. H. et al. Immune cell-stromal circuitry in lupus photosensitivity. J. Immunol. 206(2), 302\u2013309 (2021).","journal-title":"J. Immunol."},{"key":"48284_CR21","unstructured":"Ngamjarus, C. & Pattanittum, P. n4Studies: Application for sample size calculation in health science research. Version 2.3. App store (2024)."},{"key":"48284_CR22","volume-title":"Sample Size Calculation for Health Science Research","author":"C Ngamjarus","year":"2021","unstructured":"Ngamjarus, C. Sample Size Calculation for Health Science Research 1st edn. (Khon Kaen University Printing House, 2021).","edition":"1"},{"issue":"12","key":"48284_CR23","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1093\/rheumatology\/kead132","volume":"62","author":"A Onishi","year":"2023","unstructured":"Onishi, A. et al. Comparisons of SLE-DAS and SLEDAI-2K and classification of disease activity based on the SLE-DAS with reference to patient-reported outcomes. Rheumatology (Oxford) 62(12), 3909\u20133915 (2023).","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"48284_CR24","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.3390\/ijms25042026","volume":"25","author":"CT Dobrican-B\u0103ru\u021ba","year":"2024","unstructured":"Dobrican-B\u0103ru\u021ba, C. T. et al. The alarmin triad-IL-25, IL-33, and TSLP-serum levels and their clinical implications in chronic spontaneous urticaria. Int. J. Mol. Sci. 25(4), 2026 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"48284_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2025.123742","volume":"364","author":"S Armiento","year":"2025","unstructured":"Armiento, S. et al. The glycocalyx of Lacticaseibacillus paracasei NPB01 presents two different rhamnose-rich polysaccharides with non-equivalent immunomodulating activities. Carbohydr. Polym. 364, 123742 (2025).","journal-title":"Carbohydr. Polym."},{"key":"48284_CR26","first-page":"309","volume-title":"Fundamentals of Biostatistics","author":"B Rosner","year":"2000","unstructured":"Rosner, B. Fundamentals of Biostatistics 5th edn, 309 (Thomson Learning, 2000).","edition":"5"},{"issue":"7162","key":"48284_CR27","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nature06116","volume":"449","author":"R Lande","year":"2007","unstructured":"Lande, R. et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449(7162), 564\u2013565 (2007).","journal-title":"Nature"},{"issue":"1","key":"48284_CR28","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4049\/jimmunol.1100450","volume":"187","author":"E Villanueva","year":"2011","unstructured":"Villanueva, E. et al. Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J. Immunol. 187(1), 538\u2013552 (2011).","journal-title":"J. Immunol."},{"issue":"21","key":"48284_CR29","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.147671","volume":"6","author":"S Georgakis","year":"2021","unstructured":"Georgakis, S. et al. NETs decorated with bioactive IL-33 infiltrate inflamed tissues and induce IFN-\u03b1 production in patients with SLE. JCI Insight 6(21), e147671 (2021).","journal-title":"JCI Insight"},{"issue":"2","key":"48284_CR30","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1177\/0961203309350755","volume":"19","author":"LJ Lu","year":"2010","unstructured":"Lu, L. J. et al. Review: Male systemic lupus erythematosus: A review of sex disparities in this disease. Lupus 19(2), 119\u2013129 (2010).","journal-title":"Lupus"},{"issue":"5","key":"48284_CR31","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3109\/03009742.2015.1132760","volume":"45","author":"JS Hui-Yuen","year":"2016","unstructured":"Hui-Yuen, J. S., Christiano, A. M. & Askanase, A. Sex differences in genomics in lupus: Girls with systemic lupus have high interferon gene expression while boys have high levels of tumour necrosis factor-related gene expression. Scand. J. Rheumatol. 45(5), 394\u2013396 (2016).","journal-title":"Scand. J. Rheumatol."},{"issue":"3","key":"48284_CR32","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00403-014-1447-9","volume":"306","author":"A Balato","year":"2014","unstructured":"Balato, A. et al. IL-33 is regulated by TNF-\u03b1 in normal and psoriatic skin. Arch. Dermatol. Res. 306(3), 299\u2013304 (2014).","journal-title":"Arch. Dermatol. Res."},{"issue":"6","key":"48284_CR33","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.3390\/ijms23063138","volume":"23","author":"J Sarrand","year":"2022","unstructured":"Sarrand, J. & Soyfoo, M. Involvement of IL-33 in the pathophysiology of Systemic Lupus Erythematosus. Int. J. Mol. Sci. 23(6), 3138 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"48284_CR34","first-page":"485","volume":"15","author":"YM Mo","year":"2023","unstructured":"Mo, Y. M. et al. Interleukin-33 ameliorates murine Systemic Lupus Erythematosus and is associated with induction of M2 macrophage polarisation and regulatory T cells. J. Autoimmun. 15(1), 485\u2013498 (2023).","journal-title":"J. Autoimmun."},{"issue":"4","key":"48284_CR35","doi-asserted-by":"publisher","first-page":"148","DOI":"10.55133\/eji.290414","volume":"29","author":"RI Abd-Elazeem","year":"2022","unstructured":"Abd-Elazeem, R. I. et al. Serum Interleukin-33 (IL-33) in children with active Systemic Lupus Erythematosus: A cross-sectional study. Egypt. J. Immunol. 29(4), 148\u2013155 (2022).","journal-title":"Egypt. J. Immunol."},{"issue":"5","key":"48284_CR36","first-page":"656","volume":"10","author":"W Libo","year":"2016","unstructured":"Libo, W. et al. Expression of interleukin-33 in serum of systemic lupus erythematosus patients and its clinical significance. Chin. J. Clin. (Electron. Ed.) 10(5), 656\u2013662 (2016).","journal-title":"Chin. J. Clin. (Electron. Ed.)"},{"issue":"9","key":"48284_CR37","first-page":"1696","volume":"33","author":"H Yongbao","year":"2017","unstructured":"Yongbao, H. et al. Correlation between IL-33\/ST2 ratio and severity of chronic renal damage in lupus canis erythematosus. Chin. J. Pathophysiol. 33(9), 1696\u20131702 (2017).","journal-title":"Chin. J. Pathophysiol."},{"issue":"1","key":"48284_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-21859-z","volume":"8","author":"HH Xie","year":"2018","unstructured":"Xie, H. H. et al. Elevated serum Interleukin-34 level in patients with Systemic Lupus Erythematosus is associated with disease activity. Sci. Rep. 8(1), 3462 (2018).","journal-title":"Sci. Rep."},{"issue":"4","key":"48284_CR39","doi-asserted-by":"publisher","first-page":"221","DOI":"10.5114\/reum.2020.98434","volume":"58","author":"Y Adel","year":"2020","unstructured":"Adel, Y. & Sadeq, Y. Impact of IL-34, IFN-\u03b1 and IFN-\u03bb1 on activity of Systemic Lupus Erythematosus in Egyptian patients. Reumatologia 58(4), 221\u2013230 (2020).","journal-title":"Reumatologia"},{"issue":"3","key":"48284_CR40","doi-asserted-by":"publisher","first-page":"142","DOI":"10.5213\/inj.2015.19.3.142","volume":"19","author":"TY Jang","year":"2015","unstructured":"Jang, T. Y. & Kim, Y. H. Interleukin-33 and mast cells bridge innate and adaptive immunity: From the allergologist\u2019s perspective. Int. Neurourol. J. 19(3), 142\u2013150 (2015).","journal-title":"Int. Neurourol. J."},{"issue":"12","key":"48284_CR41","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1093\/cvr\/cvy166","volume":"114","author":"R Altara","year":"2018","unstructured":"Altara, R. et al. Conflicting vascular and metabolic impact of the IL-33\/sST2 axis. Cardiovasc. Res. 114(12), 1578\u20131594 (2018).","journal-title":"Cardiovasc. Res."},{"key":"48284_CR42","first-page":"73","volume":"4","author":"JV Sarma","year":"2012","unstructured":"Sarma, J. V. & Ward, P. A. New developments in C5a receptor signaling. Cell Health Cytoskelet 4, 73\u201382 (2012).","journal-title":"Cell Health Cytoskelet"},{"issue":"02","key":"48284_CR43","first-page":"188","volume":"28","author":"Y Hao","year":"2016","unstructured":"Hao, Y. & Geng, L. Recent research advances in mediators of sepsis. Chin. Crit. Care Med. 28(02), 188\u2013192 (2016).","journal-title":"Chin. Crit. Care Med."},{"key":"48284_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/srep25171","volume":"6","author":"S Stojkovic","year":"2016","unstructured":"Stojkovic, S. et al. Tissue factor is induced by Interleukin-33 in human endothelial cells: A new link between coagulation and inflammation. Sci. Rep. 6, 25171 (2016).","journal-title":"Sci. Rep."},{"issue":"Suppl 2","key":"48284_CR45","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000350363","volume":"161","author":"M Kurokawa","year":"2013","unstructured":"Kurokawa, M. et al. Interleukin-33-activated dendritic cells induce the production of thymus and activation-regulated chemokine and macrophage-derived chemokine. Int. Arch. Allergy Immunol. 161(Suppl 2), 52\u201357 (2013).","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"1","key":"48284_CR46","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1159\/000529931","volume":"15","author":"MY Mok","year":"2023","unstructured":"Mok, M. Y. et al. Interleukin-33 ameliorates murine Systemic Lupus Erythematosus and is associated with induction of M2 macrophage polarisation and regulatory T cells. J. Innate Immun. 15(1), 485\u2013498 (2023).","journal-title":"J. Innate Immun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48284-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48284-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48284-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:05:13Z","timestamp":1782957913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48284-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48284"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48284-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,2]]},"assertion":[{"value":"14 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The studies involving humans were approved by the Institutional Ethics Committee of The First Affiliated Hospital of Guangxi Medical University (Approval No: 2021-KY-\u56fd\u57fa-195). The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation was required from the participants or the participants\u2019 legal guardians\/next of kin in accordance with the national legislation and institutional requirements.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"20291"}}